<DOC>
	<DOCNO>NCT02718365</DOCNO>
	<brief_summary>The purpose study evaluate whether long-term outcome safety wedge resection comparable segmentectomy surgical treatment early stage ( IA ) non-small cell lung cancer ( NSCLC ) . Zhang et al . perform meta-analysis 53 study suggest sublobectomy achieved survival rate comparable lobectomy select population patient Stage I NSCLC . However , one critical question need address , , sublobectomy require segmentectomy wedge resection ? Cho et al . report , pulmonary ground glass opacity ( GGO ) nodule ( Stage IA NSCLC ) , wedge resection achieve 5-year survival rate 98.6 % pure GGO group 95.5 % mixed GGO group . Cho et al . caution perform wedge resection mixed GGO nodule GGO component ≤ 75 % , due high recurrence rate . When radiology show GGO component ≥75 % , pathology usually find lesion non-invasive . Therefore , lesion potential candidate wedge resection . This randomized clinical trial ass whether wedge resection establish standard treatment Stage IA NSCLC tumor size ≤ 2 cm GGO component ≥ 75 % .</brief_summary>
	<brief_title>Comparison Between Wedge Resection Segmentectomy Ground Glass Opacity- Dominant Stage IA NSCLC</brief_title>
	<detailed_description>1 . Selection procedure : When case meet inclusion criterion meet exclusion criterion , research assistant research participate center fill Eligibility Application Form submit Research Committee review whether case eligible trial . The following rule strictly apply : 1 . The application confirmation eligibility preoperatively complete postoperative application accept . 2 . If Eligibility Application Form incomplete , must return complete ; otherwise , accept . 3 . After approve Research Committee , case assign number ( Baseline Number , BN ) Eligibility Confirmation Notice send applicant . 4 . After research participate center receive Eligibility Confirmation Notice , research assistant center responsible custody documentation . 5 . Once select registration , content Eligibility Application Form input database case 's eligibility allow cancel , , relevant information delete database , unless patient decline information use study . 6 . The data center accept duplicate application single case . If happens , first register data use ( i.e. , first time BN ) . 7 . In case duplicate application registration error , research assistant research participate center shall contact Research Committee soon possible liaison documentation . 2 . Qualification responsible surgeon participate study : responsible surgeon participate study shall meet following qualification : 1 ) least complete 20 case VATS segmentectomy ; 2 ) pass blind review his/her video record surgery . 3 . Criteria confirm operation quality : case include analysis , responsible surgeon shall submit video photo recording surgery Research Committee evaluation surgical procedure . 4 . Rules handle exclude patient identify intraoperatively : responsible surgeon find patient operation meet exclusion criterion , case exclude surgeon follow routine clinical practice research participate center decide subsequent treatment specify study protocol .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Inclusion criterion : 1 . Preoperative thinsection compute tomography ( TSCT ) fulfill follow condition : Lung cancer suspect . Lesion size 5 mm equal le 20 mm . Consolidation/tumor ( C/T ) ratio equal less 0.25 . The center tumor locate out third lung field . Preoperative TSCT estimate surgical margin than1.5 cm tumor 's diameter . 2 . Preoperative clinical staging : T1aN0M0 ( accord UICC20097thTNM ) . 3 . R0 resectable segmentectomy wedge resection plus mediastinal lymph node resection . 4 . Aged 18 80 year old . 5 . No prior chemotherapy thoracic radiation therapy malignant disease . 6 . Preoperative FEV1.0 &gt; =1.0 L. 7 . Performance status ECOG 0 1 . 8 . Preoperative ASA scoring ( American society anesthesiology ) class I III . 9 . Sufficient organ function . 10 . The patient agree participate trial sign inform consent form . Exclusion criterion : 1 . Quit smoke ＜2 week . 2 . Preoperative FEV1.0 &lt; 50 % expect value . 3 . Mediastinal lymph node metastasis confirm biopsy . 4 . Pregnant lactating woman . 5 . Serious mental illness . 6 . With malignant disease history within 5 year . 7 . With history unstable angina myocardial infarction within 6 month . 8 . With history cerebral infarction cerebral hemorrhage within 6 month . 9 . With history sustain systemic corticosteroid therapy within 1 month . 10 . The patient require simultaneous surgical treatment disease . 11 . TSCT show lesion locate right middle lobe .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Lung Neoplasms</keyword>
	<keyword>Surgery</keyword>
	<keyword>VATS</keyword>
	<keyword>GGO</keyword>
	<keyword>GGN</keyword>
	<keyword>Segmentectomy</keyword>
	<keyword>Wedge Resection</keyword>
	<keyword>Prognosis</keyword>
</DOC>